올리고뉴클레오티드 합성 시장 규모, 점유율, 성장 분석 : 제품별, 유형별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Oligonucleotide Synthesis Market Size, Share, and Growth Analysis, By Product (Oligonucleotide, Reagents), By Type (Custom Oligos, Predesigned Oligos), By Application, By End User, By Region - Industry Forecast 2025-2032
상품코드:1673665
리서치사:SkyQuest Technology Consulting Pvt. Ltd.
발행일:2025년 03월
페이지 정보:영문 219 Pages
라이선스 & 가격 (부가세 별도)
한글목차
올리고뉴클레오티드 합성 시장 규모는 2023년에 78억 달러로 평가되며, 2024년 92억 1,000만 달러에서 2032년에는 348억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 18.1%로 성장할 전망입니다.
올리고뉴클레오티드 합성에 대한 세계 수요는 만성질환 유병률 증가와 의료 연구개발에 대한 막대한 투자로 인해 크게 성장할 것으로 예상됩니다. 정밀의료와 맞춤의료로의 전환이 진행되고 유전자 치료가 수용되면서 올리고뉴클레오티드 합성 공급업체에게 새로운 길을 열어줄 것으로 기대됩니다. 또한 합성 기술의 발전과 핵산 기반 치료제의 광범위한 응용으로 시장 기회는 더욱 확대될 것으로 보입니다. 북미는 활발한 헬스케어 연구비 지출에 힘입어 시장을 주도할 것으로 예상됩니다. 그러나 높은 합성 비용, 복잡한 규제 상황, 유전자 치료를 둘러싼 윤리적 고려 사항, 제한된 제조 능력 등의 문제가 이 개발도상국 시장에서의 성장을 저해할 수 있습니다.
목차
서론
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장의 전제조건과 제한
개요
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
촉진요인과 기회
억제요인과 과제
Porter의 산업 분석
주요 시장 인사이트
주요 성공 요인
경쟁의 정도
주요 투자 기회
시장 에코시스템
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
규제 분석
올리고뉴클레오티드 합성 시장 규모 : 제품별 & CAGR(2025-2032)
시장 개요
올리고뉴클레오티드
DNA
열 기반
배열 기반
RNA
테크놀러지
열 기반
배열 기반
유형
짧은 RNA 올리고(<65 nt)
긴 RNA 올리고(>65 nt)
CRISPR(sgRNA)
시약
장비
올리고뉴클레오티드 합성 시장 규모 : 유형별 & CAGR(2025-2032)
시장 개요
커스텀 올리고
프리디자인 올리고
올리고뉴클레오티드 합성 시장 규모 : 용도별 & CAGR(2025-2032)
시장 개요
치료 응용
진단
조사
기타
올리고뉴클레오티드 합성 시장 규모 : 최종사용자별 & CAGR(2025-2032)
시장 개요
학술 조사기관
제약·바이오테크놀러지 기업
진단 검사실
기타
올리고뉴클레오티드 합성 시장 규모 : 지역별 & CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽 지역
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카 지역
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
상위 5사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 개요
기업의 상세
제품 포트폴리오 분석
기업의 부문별 점유율 분석
매출의 전년대비 비교(2022-2024)
주요 기업 개요
Thermo Fisher Scientific(USA)
Merck KGaA(Germany)
Agilent Technologies(USA)
LGC Biosearch Technologies(UK)
Integrated DNA Technologies(IDT)(USA)
Eurofins Genomics(Luxembourg)
GenScript Biotech Corporation(USA)
Twist Bioscience(USA)
Bio-Synthesis Inc.(USA)
ATUM(USA)
DNA Script(France)
SGI-DNA(USA)
Eurogentec(Kaneka)(Belgium)
Creative Biogene(USA)
GeneCust Europe(Luxembourg)
Synbio Technologies(USA)
Epoch Life Science, Inc.(USA)
Bioneer Corporation(South Korea)
Genewiz(Azenta Life Sciences)(USA)
결론과 제안
KSA
영문 목차
영문목차
Oligonucleotide Synthesis Market size was valued at USD 7.8 billion in 2023 and is poised to grow from USD 9.21 billion in 2024 to USD 34.86 billion by 2032, growing at a CAGR of 18.1% during the forecast period (2025-2032).
The global demand for oligonucleotide synthesis is poised for significant growth, driven by the rising incidence of chronic diseases and substantial investments in medical research and development. The increasing shift towards precision and personalized medicine, alongside the growing acceptance of gene therapies, is expected to open new avenues for oligonucleotide synthesis providers. Additionally, advancements in synthesis technologies and the broader application of nucleic acid-based therapeutics will further enhance market opportunities. North America, supported by robust healthcare research spending, is projected to lead the market. However, challenges such as high synthesis costs, complex regulatory environments, ethical considerations surrounding gene therapies, and limited manufacturing capabilities could impede growth in this evolving landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Oligonucleotide Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Oligonucleotide Synthesis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Oligonucleotide, Reagents and Equipment. Based on Type, the market is segmented into Custom Oligos and Predesigned Oligos. Based on Application, the market is segmented into Therapeutic Applications, Diagnostics, Research and Others. Based on End User, the market is segmented into Academic Research Institutes, Pharmaceutical and Biotechnology Companies,, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Oligonucleotide Synthesis Market
The oligonucleotide synthesis market is primarily driven by the pivotal role oligonucleotides play in essential diagnostic techniques, including PCR, qPCR, and next-generation sequencing (NGS). As the demand for early diagnostic solutions rises swiftly, this trend is expected to pave the way for significant growth opportunities within the oligonucleotide synthesis sector in the future. The increasing reliance on these nucleic acid sequences in various biomedical applications highlights their importance, thereby reinforcing the market's potential to expand in response to innovations and advancements in diagnostic methodologies and technologies.
Restraints in the Oligonucleotide Synthesis Market
The oligonucleotide synthesis market faces significant constraints due to high costs associated with the production of high-purity or complex oligonucleotides, particularly those needed for therapeutic purposes. The expenses linked to purification processes and quality control measures exacerbate this financial challenge, making it difficult for smaller biotech companies to access these essential resources. As a result, the high operational costs restrict the ability of these firms to engage in oligonucleotide synthesis, ultimately hindering innovation and development within the industry. This economic barrier can limit competition and slow down advancements in therapeutic solutions reliant on oligonucleotides.
Market Trends of the Oligonucleotide Synthesis Market
The oligonucleotide synthesis market is witnessing a dynamic trend towards the integration of artificial intelligence (AI) and automation, significantly enhancing the efficiency, accuracy, and scalability of synthesis processes. These advancements are not only streamlining operational workflows but are also reducing costs, making oligonucleotide synthesis more accessible to researchers and biotech companies. Automated synthesizers combined with AI-driven design tools are increasingly popular, enabling rapid customization and development of oligonucleotides for various applications, including gene therapy and diagnostics. This technological shift is poised to transform the landscape of the oligonucleotide synthesis market, driving growth and innovation well into the future.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Global Oligonucleotide Synthesis Market Size by Product & CAGR (2025-2032)
Market Overview
Oligonucleotide
DNA
Column-based
Array-based
RNA
Technology
Column-based
Array-based
Type
Short RNA Oligos (<65 nt)
Long RNA Oligos (>65 nt)
CRISPR (sgRNA)
Reagents
Equipment
Global Oligonucleotide Synthesis Market Size by Type & CAGR (2025-2032)
Market Overview
Custom Oligos
Predesigned Oligos
Global Oligonucleotide Synthesis Market Size by Application & CAGR (2025-2032)
Market Overview
Therapeutic Applications
Diagnostics
Research
Others
Global Oligonucleotide Synthesis Market Size by End User & CAGR (2025-2032)
Market Overview
Academic Research Institutes
Pharmaceutical and Biotechnology Companies,
Diagnostic Laboratories
Others
Global Oligonucleotide Synthesis Market Size & CAGR (2025-2032)
North America (Product, Type, Application, End User)
US
Canada
Europe (Product, Type, Application, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Product, Type, Application, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Product, Type, Application, End User)
Brazil
Rest of Latin America
Middle East & Africa (Product, Type, Application, End User)
